Suppr超能文献

处方药物评审:奥瑞珠单抗

Formulary Drug Review: Ocrelizumab.

作者信息

Ali Zaynah K, Baker Danial E

机构信息

Washington State University, Spokane, USA.

出版信息

Hosp Pharm. 2017 Oct;52(9):599-606. doi: 10.1177/0018578717731733. Epub 2017 Sep 17.

Abstract

Each month, subscribers to receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of publishes selected reviews in this column. For more information about , contact Wolters Kluwer customer service at 866-397-3433.

摘要

每月,订阅者会收到5至6篇有充分文献记录的关于新发布或处于3期临床试验后期的药物的专题论文。这些专题论文面向药学与治疗学委员会。订阅者还会每月收到关于对议程以及药学/护理在职培训有用的药物的1页摘要专题论文。每月还会提供一份全面的目标药物利用评估/药物使用评估(DUE/MUE)。订阅后,专题论文可供订阅者在线获取。专题论文可进行定制以满足机构的需求。通过合作,出版方会在本专栏发表精选评论。如需了解更多关于……的信息,请致电866 - 397 - 3433联系威科集团客户服务部。

相似文献

1
Formulary Drug Review: Ocrelizumab.处方药物评审:奥瑞珠单抗
Hosp Pharm. 2017 Oct;52(9):599-606. doi: 10.1177/0018578717731733. Epub 2017 Sep 17.
2
Formulary Drug Review: Edaravone.处方药物审查:依达拉奉
Hosp Pharm. 2017 Dec;52(11):732-736. doi: 10.1177/0018578717734877. Epub 2017 Oct 9.
3
Formulary Drug Review: Betrixaban.处方药物审查:贝曲西班
Hosp Pharm. 2018 Feb;53(1):29-37. doi: 10.1177/0018578717739397. Epub 2017 Nov 6.
4
Sugammadex.舒更葡糖钠
Hosp Pharm. 2016 Jul;51(7):585-96. doi: 10.1310/hpj5107-585.
5
Insulin Degludec/Liraglutide.德谷胰岛素/利拉鲁肽
Hosp Pharm. 2017 May;52(5):374-380. doi: 10.1177/0018578717715383. Epub 2017 May 1.
6
Eteplirsen.依特普瑞森
Hosp Pharm. 2017 Apr;52(4):302-305. doi: 10.1310/hpj5204-302.
7
Angiotensin II.血管紧张素II
Hosp Pharm. 2018 Jul;53(4):230-233. doi: 10.1177/0018578718778224. Epub 2018 May 24.
8
Formulary Drug Review: Sufentanil Sublingual.处方药物评审:舒芬太尼舌下给药制剂
Hosp Pharm. 2019 Aug;54(4):222-228. doi: 10.1177/0018578719851726. Epub 2019 May 29.
9
Bezlotoxumab.贝佐妥昔单抗
Hosp Pharm. 2017 Mar;52(3):229-233. doi: 10.1310/hpj5203-229.
10
Formulary Drug Review: Etelcalcetide.处方药物评审:依特卡肽
Hosp Pharm. 2017 Nov;52(10):669-674. doi: 10.1177/0018578717733478. Epub 2017 Sep 25.

本文引用的文献

3
Therapeutic strategies targeting B-cells in multiple sclerosis.多发性硬化症中针对 B 细胞的治疗策略。
Autoimmun Rev. 2016 Jul;15(7):714-8. doi: 10.1016/j.autrev.2016.03.006. Epub 2016 Mar 9.
4
Novel Agents for Relapsing Forms of Multiple Sclerosis.新型多发性硬化症复发形式治疗药物。
Annu Rev Med. 2016;67:309-21. doi: 10.1146/annurev-med-052814-023415. Epub 2015 Sep 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验